Innospec (IOSP) Expected to Announce Quarterly Earnings on Tuesday

Key Points

• Innospec (NASDAQ:IOSP) is set to release its Q2 2025 earnings on August 5th, with anticipated earnings of $1.23 per share and revenue of $440.70 million.
• The company recently increased its semi-annual dividend from $0.79 to $0.84, providing a yield of 1.7% despite a high payout ratio of 155.56%.
• Insider Leslie J. Parrette sold 446 shares at an average price of $90.63, which represents a 7.50% reduction in their ownership stake.

Innospec (NASDAQ:IOSP - Get Free Report) is expected to release its Q2 2025 earnings data after the market closes on Tuesday, August 5th. Analysts expect Innospec to post earnings of $1.23 per share and revenue of $440.70 million for the quarter.

Innospec (NASDAQ:IOSP - Get Free Report) last issued its earnings results on Thursday, May 8th. The specialty chemicals company reported $1.42 EPS for the quarter, topping analysts' consensus estimates of $1.40 by $0.02. The business had revenue of $440.80 million for the quarter, compared to the consensus estimate of $466.50 million. Innospec had a net margin of 1.51% and a return on equity of 11.38%. The company's revenue for the quarter was down 11.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.75 EPS. On average, analysts expect Innospec to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Innospec Stock Performance

IOSP traded down $1.35 during trading on Friday, hitting $78.55. The stock had a trading volume of 238,504 shares, compared to its average volume of 187,405. The stock has a 50 day simple moving average of $85.26 and a two-hundred day simple moving average of $93.87. Innospec has a twelve month low of $77.58 and a twelve month high of $128.35. The company has a market capitalization of $1.96 billion, a PE ratio of 72.73 and a beta of 1.07.

Insiders Place Their Bets

In other news, Director Leslie J. Parrette sold 446 shares of the stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $90.63, for a total value of $40,420.98. Following the completion of the transaction, the director owned 5,497 shares in the company, valued at $498,193.11. This trade represents a 7.50% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.31% of the stock is currently owned by corporate insiders.

Institutional Trading of Innospec

A number of hedge funds have recently made changes to their positions in IOSP. Baird Financial Group Inc. boosted its holdings in shares of Innospec by 11.5% during the first quarter. Baird Financial Group Inc. now owns 2,170 shares of the specialty chemicals company's stock valued at $206,000 after acquiring an additional 223 shares during the period. NewEdge Advisors LLC lifted its stake in Innospec by 37.4% during the first quarter. NewEdge Advisors LLC now owns 4,567 shares of the specialty chemicals company's stock valued at $433,000 after buying an additional 1,243 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Innospec by 4.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,833 shares of the specialty chemicals company's stock valued at $1,405,000 after purchasing an additional 645 shares during the period. Jane Street Group LLC increased its holdings in Innospec by 1,551.5% in the first quarter. Jane Street Group LLC now owns 95,243 shares of the specialty chemicals company's stock worth $9,024,000 after buying an additional 89,476 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Innospec by 14.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 101,773 shares of the specialty chemicals company's stock worth $9,643,000 after buying an additional 12,755 shares during the last quarter. Hedge funds and other institutional investors own 96.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on IOSP. Seaport Res Ptn upgraded shares of Innospec from a "hold" rating to a "strong-buy" rating in a research report on Monday, April 21st. Wall Street Zen downgraded shares of Innospec from a "buy" rating to a "hold" rating in a research note on Tuesday, May 6th.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.